Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
Benzarlizumab
Benzarlizumab
Brand names: Fasenra
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | 30 mg/mL (1 mL) |
Last updated: Apr. 2, 2021
Benzarlizumab
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | 30 mg/mL (1 mL) |
Benzarlizumab (Fasenra) is non-formulary for inpatient use. Ordering limited to outpatient use in pulmonary clinic or infusion clinics and prescribing by pulmonologists or ANP only.